Healthcare - Press Releases

Published on Fri 7 Mar 2025 9:58:31 UTC
CAMBRIDGE, Mass., March 7, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced to unveil its innovative AI-assisted drug discovery engine, Hu-mAtrIxTM. This new platform, powered by advanced artificial intelligence, integrates seamlessly with the company's proprietary Harbour Mice technology platform, aiming to accelerate antibody discovery across multiple key therapeutic areas, including neurodegenerative and metabolic diseases, and more.
Published on Fri 7 Mar 2025 9:58:21 UTC
SHENZHEN, China, March 7, 2025 /PRNewswire/ --The latest scientific research at the deepest part of the ocean has revealed something extraordinary - biodiversity is extensive and flourishing despite the extreme conditions.
Published on Fri 7 Mar 2025 9:57:34 UTC
BARCELONA, Spain, March 7, 2025 /PRNewswire/ -- During the Mobile World Congress (MWC) 2025, Huawei held a global healthcare industry session themed Digital Intelligence Drives Inclusive Healthcare. Expertsshared their latest strategies and practices in digital transformation and AI application development.
Published on Fri 7 Mar 2025 9:57:01 UTC
HONG KONG and SHANGHAI, March 7, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", "the Company" or the "Group"HKEX: 2318 / 82318; SSE: 601318) ranks first in global patents in healthcare and fintech, according to two new reports from the Intellectual Property Publishing House. The "Fintech Industry 2024 Patent Analysis White Paper"and the "Healthcare Industry 2024 Patent Analysis White Paper" included each industry's Global Patentee Top 10 list from 2019 to 2024.The figures demonstrate Ping An's strength in cutting-edge technology innovation and applications.
Published on Fri 7 Mar 2025 2:17:54 UTC
FREDERICK, Md., March 6, 2025 /PRNewswire/ -- Frederick Innovative Technology Center, Inc. (FITCI) is proud to announce the appointment of Andres Mendoza as the new Vice Chairman of the FITCI Board of Directors. Andres brings a wealth of experience and an entrepreneurial spirit to this leadership role, further strengthening FITCI's mission to drive innovation and support the growth of startups in Frederick and beyond.
Published on Fri 7 Mar 2025 2:17:49 UTC
RANCHO CUCAMONGA, Calif., March 6, 2025 /PRNewswire/ --Inland Empire Health Plan (IEHP) will host free well-child mobile clinics at the health plan's Community Wellness Centers in Riverside, San Bernardino and Victorville.
Published on Fri 7 Mar 2025 2:17:33 UTC
SALT LAKE CITY, March 6, 2025 /PRNewswire/ --Co-Diagnostics, Inc.(Nasdaq: CODX)(the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 4, 2025, the Securities & Governance Litigation Team at BakerHostetler, the legal firm retained to represent the Company, won complete dismissal on summary judgment of a Section 10(b) securities class action that had been pending against the Company in the United States District Court for the District of Utah. See Gelt Trading, Ltd. v. Co-Diagnostics, Inc. et al., Case No. 2:20-cv-00368-JNP-DBP (D. Utah).
Published on Fri 7 Mar 2025 2:17:31 UTC
Company Reaffirms Commitment to Patient Care Amid Leadership Change.
Published on Fri 7 Mar 2025 2:17:26 UTC
Winston-Salem-based Digital Health Company Receives Two Prestigious Awards at ViVE Event in Nashville, TN
Published on Fri 7 Mar 2025 2:17:24 UTC
GALWAY, Ireland, March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) onThursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0.70per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company inMay 2024. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 47 consecutive years. The dividend is payable onApril 11, 2025, to shareholders of record at the close of business onMarch 28, 2025.
Published on Fri 7 Mar 2025 2:17:21 UTC
--Dosing ongoing in Phase 1 clinical trial cohorts evaluating Claudin 18.2 ADC EO-3021 in combination with ramucirumab or dostarlimab in patients with advanced gastric/gastroesophageal junction (GEJ) cancer --
Published on Fri 7 Mar 2025 2:17:15 UTC
MEXICO CITY, March 6, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V.(BMV: LABB)("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding.
Published on Fri 7 Mar 2025 2:17:13 UTC
Fort Lauderdale business owner recognized by world's oldest and largest franchising association during Annual Convention in Las Vegas; Recognized for excellence in business, giving back, and providing opportunities to those around them.
Published on Fri 7 Mar 2025 2:17:00 UTC
Daniel M. Skovronsky, MD, PhD, of Eli Lilly & Company, Receives Prestigious 2025 Melvin R. Goodes Prize, Nobel Prize of Alzheimer's Research
Published on Fri 7 Mar 2025 2:16:57 UTC
With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but TEPMETKO's once-daily dosing and efficacy profile offer differentiation.
Published on Fri 7 Mar 2025 2:16:54 UTC
The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional neuroradiology. As these conditions become more common, there is a growing need for minimally invasive diagnostic and treatment methods to enhance patient outcomes and shorten recovery periods.
Published on Fri 7 Mar 2025 2:16:51 UTC
GREENWOOD VILLAGE, Colo., March 6, 2025 /PRNewswire/ -- Catalyst Solutions, a leader in innovative health plan optimization, announced today that Lisa Hettinger has joined the company as a member of the Advisory Board focused on Government Solutions. Hettinger brings more than 30 years of leadership experience in healthcare, including a distinguished tenure as Chief Financial Officer and State Medicaid Director at the Idaho Department of Health and Welfare.
Published on Fri 7 Mar 2025 2:15:00 UTC
VANCOUVER, BC, March 6, 2025 /PRNewswire/ -GBM Health Holding, a global leader in integrated healthcare innovation, is proud to announce that its subsidiariesGene Biotechnology Enterprises Ltd(Operating business as: "Gene Bio Medical")and Geno10X Bioscience Inchave been awarded a combined $1.5 million CAD in funding from Innovate BC. The grants, part of Innovate BC's Ignite Program, will accelerate the development of cutting-edge clean technology and life sciences solutions poised to transform healthcare and environmental sustainability.
Published on Fri 7 Mar 2025 2:13:06 UTC
Get $31.30 Off Any Purchase of $125 in Celebration of 313 Day
Published on Fri 7 Mar 2025 2:12:20 UTC
WASHINGTON, March 6, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle,Kumapley Lartevi, MD is acknowledged as a 2025 Pinnacle Lifetime Member for his contributions to Providing Quality Care to the Community.
Published on Fri 7 Mar 2025 2:12:16 UTC
MANDEVILLE, La., March 6, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, James W. Christopher, MD, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Surgeon Committed to Excellence in Minimally Invasive Surgery.
Published on Fri 7 Mar 2025 2:10:29 UTC
The network is bringing together thought leaders, branding experts, and healthcare professionals in their Paris Village to explore the latest transformational impact of GLP-1 treatments emerging and disrupting the European market.
Published on Fri 7 Mar 2025 2:06:49 UTC
NASHVILLE, Tenn., March 6, 2025 /PRNewswire/ -- SLD Technology, a major sponsor, in collaboration with the Association of Medical Facility Professionals (AMFP) and SquareFootage.net is proud to present the 2025 D4Z Healthcare Summit, an exclusive industry event dedicated to advancing healthcare design, innovation and the reduction of healthcare harm. Taking place at the Omni Hotel in Nashville, TN, this non-profit event will donate all net proceeds to St. Jude Children's Hospital, supporting its mission to treat and cure pediatric catastrophic diseases.
Published on Thu 6 Mar 2025 11:06:06 UTC
American Lung Association report examines the use of satellite-derived data to track unhealthy levels of NO
Published on Thu 6 Mar 2025 11:06:03 UTC
ROCKVILLE, Md., 6 mars 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), un partenaire de dveloppement de traitements de pointe du gne aux BPF, a annonc aujourd'hui la nomination de John Chiminski et de Karen Flynn en tant que membres non excutifs de son conseil d'administration. John sera le prsident du conseil d'administration et EW Healthcare Partners a dsign Karen pour siger au conseil d'administration de la socit en tant que l'un de ses reprsentants. Leur leadership et leur expertise approfondie du secteur seront essentiels pour permettre Ascend de renforcer ses capacits et de se positionner en vue de la croissance.